Loading company…
Riskpilot
← Back to search
Sign in
Get full access
INTEGUMENTUM AS
AS
Active
Org 929274202
Skøyen terrasse 23, 0276 Oslo
Medical specialists activities · NACE 8622
Est. 2022
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 538K
-40% vs 2024
EBITDA margin
98.5%
-40% vs 2024
Equity ratio
92.5%
Financial strength
Net profit 2025
NOK 454K
+190% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2022
1M
+100%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 538K
-40%
EBITDA
NOK 530K
-40%
Net profit
NOK 454K
+190%
Total assets
NOK 1,7M
+28%
Equity
NOK 1,6M
+40%
Employees
0
—
Company information
Legal name
INTEGUMENTUM AS
Org number
929274202
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
31. mai 2022
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Legevirksomhet og finansiell investering.
Contact
Address
Skøyen terrasse 23, 0276 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
1M
2025
Income statement
NOK thousands
Item
2022
2023
2024
2025
Revenue
349
1 013
898
538
Staff expenses
−0
−5
−0
−1
EBITDA
323
903
890
530
Depreciation & amort.
−0
−0
−0
−0
EBIT
323
903
890
530
Net financials
0
5
−529
53
Profit before tax
323
908
361
582
Tax
71
199
205
128
Net profit
252
710
156
454
Balance sheet
NOK thousands
Item
2022
2023
2024
2025
Total assets
348
1 186
1 348
1 726
Equity
276
986
1 142
1 596
Long-term debt
0
0
0
0
Short-term debt
71
200
205
130
Total debt
71
200
205
130
Financial ratios
5-year trend
EBITDA margin
98.5%
This company
15.8%
Market median
+523% vs market
2022
2025
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
2022
2025
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
2022
2025
Net profit margin
84.4%
This company
8.1%
Market median
+942% vs market
2022
2025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
2022
2025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MA
Martin André Enger
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of INTEGUMENTUM AS also hold positions in
0
other companies.
Person
Role here
Other companies
Martin André Enger
Chairman
0 companies